Description
Description
Tirzee (Tirzepatide) is a once-weekly, subcutaneous injection by Getz Pharma used to treat Type 2 diabetes and obesity by acting as a GIP and GLP-1 receptor agonist.
It promotes significant weight loss, improves glycemic control, and is available as a prefilled pen in Pakistan from CSH Pharmacy.
Key Details for Tirzee (Tirzepatide):
Purpose: Treats Type 2 diabetes mellitus as an adjunct to diet and exercise; also used for weight management in overweight/obese adults.
Mechanism: Dual action (GIP and GLP-1 receptor agonist) mimics hormones to increase insulin, decrease glucagon, reduce appetite, and slow gastric emptying.
Dosage & Administration: Administered as a once-weekly injection, typically into the stomach or thigh. It is a cold-chain item, meaning it requires refrigeration.
Strength Availability: Available in various strengths, including 2.5mg, 5mg, 7.5mg, and 10mg/0.5mL.
Manufacturer: Produced by Getz Pharma.
Important Information:
Safety: Do not share pens. It is a prescription-only medication.
Side Effects: Common side effects often relate to gastrointestinal issues, such as nausea or diarrhea.
Disclaimer: This information is for informational purposes only. Consult a healthcare professional for diagnosis, treatment, and before starting any weight loss medication.



